Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.50 |
| ▸ | CTSG | P08311 | 2/20 | 0.50 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.50 |
| ▸ | CMA1 | P23946 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | NPC1 | O15118 | 4/20 | 0.49 |
| ▸ | RAB9A | P51151 | 4/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4005311 | 0.84 | TDP1 (0.55) | GAASMN1; SMN2LMNAPOLBALDH1A1 | |
| SCHEMBL1937041 | 0.83 | GAA (0.59) | GAASMN1; SMN2LMNAPOLBHPGD | |
| SCHEMBL22373759 | 0.83 | SMN1; SMN2 (0.50) | GAASMN1; SMN2LMNAPOLBHPGD | |
| SCHEMBL28263034 | 0.82 | KMT2A (0.48) | SMN1; SMN2LMNAHPGDALDH1A1NPC1 | |
| SCHEMBL3363014 | 0.82 | MEN1 (0.54) | GAASMN1; SMN2LMNAALDH1A1NPC1 | |
| SCHEMBL8331737 | 0.82 | MEN1 (0.68) | GAASMN1; SMN2LMNAPOLBHPGD | |
| SCHEMBL28391999 | 0.82 | POLB (0.49) | GAASMN1; SMN2LMNAPOLBHPGD | |
| SCHEMBL6798202 | 0.82 | HDAC8 (0.56) | GAASMN1; SMN2LMNAPOLBALDH1A1 | |
| SCHEMBL3136322 | 0.81 | HPGD (0.62) | GAASMN1; SMN2LMNAPOLBHPGD | |
| SCHEMBL4008989 | 0.80 | MEN1 (0.53) | SMN1; SMN2LMNAHPGDALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129064-A1 | PRODRUGS OF 2-BROMO-LSD (2-BROMOLYSERGIC ACID DIETHYLAMIDE) | TERRAN BIOSCIENCES INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250049748-A1 | ANALOGS OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE | TERRAN BIOSCIENCES INC (US) | 2025-02-13 | — | — | US | disclosed |
| WO-2023141636-A1 | PRODRUGS OF 2-BROMO-LSD (2-BROMOLYSERGIC ACID DIETHYLAMIDE) | TERRAN BIOSCIENCES INC. (US) | 2023-07-27 | — | — | WO | disclosed |
| WO-2023141636-A1 | PRODRUGS OF 2-BROMO-LSD (2-BROMOLYSERGIC ACID DIETHYLAMIDE) | TERRAN BIOSCIENCES INC. (US) | 2023-07-27 | — | — | WO | disclosed |
| WO-2023115002-A1 | ANALOGS OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE | TERRAN BIOSCIENCES INC. (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20090298890-A1 | NEW N-METHYL BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2009-12-03 | — | — | US | disclosed |
| US-7528134-B2 | Acetamides and benzamides that are useful in treating sexual dysfunction | ABBOTT LABORATORIES INC. (US) | 2009-05-05 | — | — | US | disclosed |
| EP-2049489-A2 | N-METHYL BENZAMIDE DERIVATIVES USEFUL AS FUNGICIDES | Bayer CropScience SA (FR) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008081011-A1 | N-METHYL CARBOXAMIDE DERIVATIVES USEFUL AS FUNGICIDES | BAYER CROPSCIENCE SA (FR) | 2008-07-10 | — | — | WO | disclosed |
| WO-2008003744-A2 | N-METHYL BENZAMIDE DERIVATIVES USEFUL AS FUNGICIDES | BAYER CROPSCIENCE SA (FR) | 2008-01-10 | — | — | WO | disclosed |
| US-5130328-A | Lima bean leaves | AMERICAN CYANAMID COMPANY (US) | 1992-07-14 | — | — | US | disclosed |
| US-4427689-A | ANTIBACTERIAL AGENTS, LACTAMASE INHIBITORS | BEECHAM GROUP LIMITED (GB) | 1984-01-24 | — | — | US | disclosed |
| US-4426377-A | BACTERICIDES | BEECHAM GROUP LIMITED (GB) | 1984-01-17 | — | — | US | disclosed |
| US-4372946-A | ENZYME INHIBITORS, BACTERICIDES | BEECHAM GROUP LIMITED (GB) | 1983-02-08 | — | — | US | disclosed |
| EP-0008899-B1 | CLAVULANIC ACID DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1982-09-15 | — | — | EP | disclosed |
| EP-0001333-B1 | CLAVULANIC ACID DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1982-09-15 | — | — | EP | disclosed |
| US-4244965-A | B-LACTAMASE INHIBITORS AND BACTERICIDES | BEECHAM GROUP LIMITED (GB) | 1981-01-13 | — | — | US | disclosed |
| US-4215128-A | INHIBITORS OF BETA-LACTAMASE, ANTIBACTERIAL | BEECHAM GROUP LIMITED (GB) | 1980-07-29 | — | — | US | disclosed |
| EP-0008899-A1 | Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1980-03-19 | — | — | EP | disclosed |
| EP-0001333-A1 | Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1979-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049748-A1 | ANALOGS OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE | PNMT, HNMT, COMT | GAA 1277/4885SMN1; SMN2 405/4885LMNA 2583/4885 |
| US-20090298890-A1 | NEW N-METHYL BENZAMIDE DERIVATIVES | CYP51A1, GANAB, ERG28 | GAA 57/4885SMN1; SMN2 2040/4885LMNA 1888/4885 |
| US-20250129064-A1 | PRODRUGS OF 2-BROMO-LSD (2-BROMOLYSERGIC ACID DIETHYLAMIDE) | GBA2, GBA1, SLC18A2 | GAA 59/4885SMN1; SMN2 1954/4885LMNA 1016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.